Bausch Health Cos Retained Earnings (Accumulated Deficit) 2010-2024 | BHC
Bausch Health Cos retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Bausch Health Cos Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2023 |
$-9,778 |
| 2022 |
$-9,186 |
| 2021 |
$-8,961 |
| 2020 |
$-8,013 |
| 2019 |
$-7,452 |
| 2018 |
$-5,664 |
| 2017 |
$-2,725 |
| 2016 |
$-5,129 |
| 2015 |
$-2,750 |
| 2014 |
$-2,398 |
| 2013 |
$-3,279 |
| 2012 |
$-2,371 |
| 2011 |
$-2,030 |
| 2010 |
$-935 |
| 2009 |
$-246 |
Bausch Health Cos Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024-09-30 |
$-9,917 |
| 2024-06-30 |
$-9,832 |
| 2024-03-31 |
$-9,842 |
| 2023-12-31 |
$-9,778 |
| 2023-09-30 |
$-9,739 |
| 2023-06-30 |
$-9,361 |
| 2023-03-31 |
$-9,387 |
| 2022-12-31 |
$-9,186 |
| 2022-09-30 |
$-8,776 |
| 2022-06-30 |
$-9,175 |
| 2022-03-31 |
$-9,030 |
| 2021-12-31 |
$-8,961 |
| 2021-09-30 |
$-9,030 |
| 2021-06-30 |
$-9,218 |
| 2021-03-31 |
$-8,623 |
| 2020-12-31 |
$-8,013 |
| 2020-09-30 |
$-7,860 |
| 2020-06-30 |
$-7,931 |
| 2020-03-31 |
$-7,605 |
| 2019-12-31 |
$-7,452 |
| 2019-09-30 |
$-5,936 |
| 2019-06-30 |
$-5,887 |
| 2019-03-31 |
$-5,716 |
| 2018-12-31 |
$-5,664 |
| 2018-09-30 |
$-5,320 |
| 2018-06-30 |
$-4,970 |
| 2018-03-31 |
$-4,209 |
| 2017-12-31 |
$-2,725 |
| 2017-09-30 |
$-3,239 |
| 2017-06-30 |
$-4,539 |
| 2017-03-31 |
$-4,502 |
| 2016-12-31 |
$-5,129 |
| 2016-09-30 |
$-4,614 |
| 2016-06-30 |
$-3,426 |
| 2016-03-31 |
$-3,123 |
| 2015-12-31 |
$-2,750 |
| 2015-09-30 |
$-2,339 |
| 2015-06-30 |
$-2,388 |
| 2015-03-31 |
$-2,291 |
| 2014-12-31 |
$-2,398 |
| 2014-09-30 |
$-2,900 |
| 2014-06-30 |
$-3,175 |
| 2014-03-31 |
$-3,301 |
| 2013-12-31 |
$-3,279 |
| 2013-09-30 |
$-3,402 |
| 2013-06-30 |
$-2,429 |
| 2013-03-31 |
$-2,424 |
| 2012-12-31 |
$-2,371 |
| 2012-09-30 |
$-2,282 |
| 2012-06-30 |
$-2,246 |
| 2012-03-31 |
$-2,116 |
| 2011-12-31 |
$-2,030 |
| 2011-09-30 |
$-2,056 |
| 2011-06-30 |
$-1,887 |
| 2011-03-31 |
$-1,207 |
| 2010-12-31 |
$-935 |
| 2010-09-30 |
$-468 |
| 2010-06-30 |
$-245 |
| 2010-03-31 |
$-263 |
| 2009-12-31 |
$-246 |
| 2009-09-30 |
$-305 |
| 2009-06-30 |
$-331 |
| 2009-03-31 |
$-340 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.358B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
